Intravaginal magnesium sulfate as an alternative to intravenous dexamethasone for labor acceleration: first direct comparison in a bayesian adaptive trial

Read full text Summarise with VIRAT
Authors: Kobra Hosseini, Mahin Seifi Alan, Leila Asadpoor asl, Niloofar Seighali, Haniyeh Rashidi, Bita Badehnoosh, Hadith Rastad
Cited by: 0
References: 26

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

OBJECTIVE: Labor acceleration remains a major challenge in obstetric care. Although intravenous (IV) dexamethasone has been shown to be effective for labor acceleration, its systemic adverse effects limit its use. Intravaginal magnesium sulfate (MgSO4) may offer a potential alternative; however, comparative studies are needed. This study compared the safety and efficacy of these interventions for labor acceleration. METHODS: This Bayesian adaptive, three-arm randomized controlled trial enrolled 150 women in latent labor and assigned them to receive intravaginal MgSO4 (50%; 10 mL), IV dexamethasone (8 mg), or usual care. The primary outcomes were labor duration and change in Bishop score; secondary outcomes included Apgar scores. RESULTS: Both active treatments significantly improved Bishop scores compared with control at 6 hours (3.06 vs. 3.05 points; P

Fields of Study & Subjects

Maternal and Perinatal Health Interventions Preterm Birth and Chorioamnionitis Anesthesia and Pain Management

Publication details

Journal / source
Obstetrics & Gynecology Science
Volume
69
Issue
3
Pages
172–182
Publication date
30 March 2026
Language
EN